Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 14, 2020

SELL
$46.4 - $67.43 $2.58 Million - $3.76 Million
-55,700 Closed
0 $0
Q2 2018

Aug 09, 2018

BUY
$50.53 - $62.98 $591,201 - $736,866
11,700 Added 26.59%
55,700 $3.08 Million
Q3 2017

Nov 15, 2017

BUY
$55.23 - $63.74 $2.43 Million - $2.8 Million
44,000
44,000 $2.81 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $120B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Opus Investment Management Inc Portfolio

Follow Opus Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Opus Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Opus Investment Management Inc with notifications on news.